A New View into the Regulation of Purine Metabolism: The Purinosome
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Other than serving as building blocks for DNA and RNA, purines metabolites provide a cell with the necessary energy and cofactors to promote cell survival and proliferation. A renewed interest in how purine metabolism may fuel cancer progression has uncovered a new perspective into how a cell regulates purine need. Under cellular conditions of high purine demand, the de novo purine biosynthetic enzymes cluster near mitochondria and microtubules to form dynamic multi-enzyme complexes referred to as purinosomes. This review highlights the purinosome as a novel level of metabolic organization of enzymes in cells, its consequences for regulation of purine metabolism, and the extent that purine metabolism is being targeted for the treatment of cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 1×
“A recent framework explains the role of altered cellular metabolism in tumorigenesis and outlines the bioenergetics and biomolecular needs of cancer cells [67].”
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · cited 1×
“A characteristic feature in numerous diseases, including cancer, is the reprogramming of metabolic processes, often resulting from genetic mutations [66].”
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · cited 1×
“Moreover, mTOR has been shown to promote the expression of genes associated with the pentose phosphate pathway that leads to the biosynthesis of PRPP, the substrate for the first reaction in the de novo purine biosynthetic pathway (Figure 1) [62].”
Quantitative flux analysis reveals folate-dependent NADPH production
Fan, J., Ye, J., Kamphorst, J. J., Shlomi, T., Thompson, C. B., & Rabinowitz, J. D. (2014) · Nature · doi:10.1038/nature13236 · Cited by 1,114 · cited 8×
“Transformation of PRA to N-formylglycinamide ribonucleotide (FGAR) via glycine and formyl group addition is catalyzed by the phosphoribosylglycinamide synthetase (GARS) and phosphoribosylglycinamide formyltransferase (GAR Tfase) domains of GART (also referred to as TrifGART).”
InfluentialA Census of Human Soluble Protein Complexes
Havugimana, P. C., Hart, G. T., Nepusz, T., Yang, H., Turinsky, A. L., Li, Z., Wang, P. I., Boutz, D. R., Fong, V., Phanse, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.011 · Cited by 860
mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. H., Asara, J. M., & Manning, B. D. (2016) · Science · doi:10.1126/science.aad0489 · Cited by 795
Structure-based prediction of protein–protein interactions on a genome-wide scale
Zhang, Q. C., Petrey, D., Deng, L., Qiang, L., Shi, Y., Thu, C. A., Bisikirska, B., Lefebvre, C., Accili, D., Hunter, T., et al. (2012) · Nature · doi:10.1038/nature11503 · Cited by 723 · cited 18×
“Transformation of PRA to N-formylglycinamide ribonucleotide (FGAR) via glycine and formyl group addition is catalyzed by the phosphoribosylglycinamide synthetase (GARS) and phosphoribosylglycinamide formyltransferase (GAR Tfase) domains of GART (also referred to as TrifGART).”
InfluentialMetabolic Reprogramming: the Emerging Concept and Associated Therapeutic Strategies
Yoshida, G. J. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0221-y · Cited by 716
Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer
Parker, W. B. (2009) · Chemical Reviews · doi:10.1021/cr900028p · Cited by 622 · cited 2×
“Purine anti-metabolites (thiopurine and deoxypurine analogs) often are prodrugs and upon intracellular conversion to the active drug molecule, stall DNA replication through inhibition of replicative enzymes or integrate into DNA/RNA causing DNA damage, gene silencing, and/or the induction of apoptosis [71].”
Nilsson, R., Jain, M., Madhusudhan, N., Sheppard, N. G., Strittmatter, L., Kampf, C., Huang, J., Asplund, A., & Mootha, V. K. (2014) · Nature Communications · doi:10.1038/ncomms4128 · Cited by 607
Cited by
From purines to purinergic signalling: molecular functions and human diseases
Huang, Z., Xie, N., Illes, P., Di Virgilio, F., Ulrich, H., Semyanov, A., Verkhratsky, A., Sperlagh, B., Yu, S.-G., Huang, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00553-z · Cited by 489
Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy
Yin, J., Ren, W., Huang, X., Deng, J., Li, T., & Yin, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01697 · Cited by 450
The role of dynamic enzyme assemblies and substrate channelling in metabolic regulation
Sweetlove, L. J., & Fernie, A. R. (2018) · Nature Communications · doi:10.1038/s41467-018-04543-8 · Cited by 416
Biochemistry of Mitochondrial Coenzyme Q Biosynthesis
Stefely, J. A., & Pagliarini, D. J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.06.008 · Cited by 331
Metabolomics and mass spectrometry imaging reveal channeled de novo purine synthesis in cells
Pareek, V., Tian, H., Winograd, N., & Benkovic, S. J. (2020) · Science · doi:10.1126/science.aaz6465 · Cited by 307
Self-citationLight-based control of metabolic flux through assembly of synthetic organelles
Zhao, E. M., Suek, N., Wilson, M. Z., Dine, E., Pannucci, N. L., Gitai, Z., Avalos, J. L., & Toettcher, J. E. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0284-8 · Cited by 290
Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
Villa, E., Ali, E., Sahu, U., & Ben-Sahra, I. (2019) · Cancers · doi:10.3390/cancers11050688 · Cited by 281
Huang, L., Sun, H., Sun, L., Shi, K., Chen, Y., Ren, X., Ge, Y., Jiang, D., Liu, X., Knoll, W., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35696-2 · Cited by 266
De novo and salvage purine synthesis pathways across tissues and tumors
Tran, D. H., Kim, D., Kesavan, R., Brown, H., Dey, T., Soflaee, M. H., Vu, H. S., Tasdogan, A., Guo, J., Bezwada, D., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.011 · Cited by 213
Regulatory mechanisms of one-carbon metabolism enzymes
Petrova, B., Maynard, A. G., Wang, P., & Kanarek, N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105457 · Cited by 103
A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight
Cuthbertson, C. R., Arabzada, Z., Bankhead, A., Kyani, A., & Neamati, N. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00223 · Cited by 57
Ajoy, R., Lo, Y.-C., Ho, M.-H., Chen, Y.-Y., Wang, Y., Chen, Y.-H., Jing-Yuan, C., Changou, C. A., Hsiung, Y.-C., Chen, H.-M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01103-3 · Cited by 57
Ubiquitous purine sensor modulates diverse signal transduction pathways in bacteria
Monteagudo-Cascales, E., Gumerov, V. M., Fernández, M., Matilla, M. A., Gavira, J. A., Zhulin, I. B., & Krell, T. (2024) · Nature Communications · doi:10.1038/s41467-024-50275-3 · Cited by 27
Genetic control over biogenic crystal morphogenesis in zebrafish
Deis, R., Lerer-Goldshtein, T., Baiko, O., Eyal, Z., Brenman-Begin, D., Goldsmith, M., Kaufmann, S., Heinig, U., Dong, Y., Lushchekina, S., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-024-01722-1 · Cited by 24
Enzyme co-localisation: Mechanisms and benefits
Kondrat, S., Krauss, U., & von Lieres, E. (2022) · Current Research in Chemical Biology · doi:10.1016/j.crchbi.2022.100031 · Cited by 19
Cell shapes decode molecular phenotypes in image-based spatial proteomics
Le, T., Leineweber, W. D., Viana, M. P., Cesnik, A., Hansen, J. N., Ouyang, W., Rafelski, S. M., & Lundberg, E. (2026) · Cell Systems · doi:10.1016/j.cels.2026.101589 · Cited by 3
Metadata
- Authors
- Pedley, A. M., & Benkovic, S. J.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 42
- Issue
- 2
- Pages
- 141-154
- ISSN
- 0968-0004 (ISSN-L)
- OpenAlex
- W2540503396
- Cited by
- 576
- References
- 79
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.